title: In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
authors.affiliation: Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø, Tromsø, Norway.
authors.forename: Johanna
authors.initials: J
authors.lastname: Kanzer
authors.forename: Ingunn
authors.initials: I
authors.lastname: Tho
authors.forename: Gøril Eide
authors.initials: GE
authors.lastname: Flaten
authors.forename: Markus
authors.initials: M
authors.lastname: Mägerlein
authors.forename: Peter
authors.initials: P
authors.lastname: Hölig
authors.forename: Gert
authors.initials: G
authors.lastname: Fricker
authors.forename: Martin
authors.initials: M
authors.lastname: Brandl
mesh_terms: D018938:Caco-2 Cells; D002118:Calcium; D002368:Castor Oil; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004058:Diffusion; D004304:Dosage Forms; D017097:Electric Impedance; D005079:Excipients; D005452:Fluoresceins / Q000737:chemistry; D005615:Freezing; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D008274:Magnesium; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000737:chemistry*; D010743:Phospholipids / Q000737:chemistry*; D012995:Solubility; D013501:Surface-Active Agents; D014867:Water
chemical_list: D004304:Dosage Forms; D005079:Excipients; D005452:Fluoresceins; D004364:Pharmaceutical Preparations; D010743:Phospholipids; D013501:Surface-Active Agents; D014867:Water; D002368:Castor Oil; D008274:Magnesium; D002118:Calcium; C007740:fluorexon